Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Cormorant Asset Management, LP Create: Alert

All | News | Filings
Date FiledTypeDescription
04/24/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/13/2023 SC 13G/A Cormorant Asset Management, LP reports a 17.7% stake in Ambrx Biopharma Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8.4% stake in Elevation Oncology, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 9.2% stake in Design Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.1% stake in GreenLight Biosciences Holdings, PBC
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8.7% stake in Immuneering Corporation
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6% stake in Ambrx Biopharma Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6% stake in Monte Rosa Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8% stake in BioAtla, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 8% stake in Aerovate Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.8% stake in Cabaletta Bio, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4.7% stake in Arcellx, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 5.2% stake in Olema Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 5.3% stake in Altimmune, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 2.7% stake in Viridian Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 10% stake in Longboard Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.5% stake in Tarsus Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 6.3% stake in Astria Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4% stake in VectivBio Holding AG
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4.7% stake in Tango Therapeutics, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 4.5% stake in Prometheus Biosciences, Inc.
02/14/2023 SC 13G/A Cormorant Asset Management, LP reports a 10% stake in Eledon Pharmaceuticals, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 10% stake in Longboard Pharmaceuticals, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 4.8% stake in Prometheus Biosciences, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 4% stake in Galecto, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 9.8% stake in Forma Therapeutics Holdings, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 4.1% stake in Cabaletta Bio, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 0% stake in C4 Therapeutics Holdings, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 7.5% stake in Aerovate Therapeutics, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 3.3% stake in Revolution Medicines, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 7.1% stake in Ambrx Biopharma Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 6.5% stake in Monte Rosa Therapeutics, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 9.8% stake in Design Therapeutics, Inc.
02/14/2022 SC 13G/A Cormorant Asset Management, LP reports a 5.8% stake in BioAtla, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy